FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to the chemical and pharmaceutical industry and provides a pharmaceutical composition with anti-inflammatory activity, consisting of: one or more nonsteroidal anti-inflammatory drugs (NSAIDs) in an amount of 10 % to 30 % by weight based on the weight of the pharmaceutical composition; one or more solid fats in an amount of 20 % to 50 % by weight based on the weight of the pharmaceutical composition; partially hydrolysed glycerol lipid in an amount of 10 % to 30 % by weight of the pharmaceutical composition, where the partially hydrolysed glycerol lipid consists of a mixture of mono-, di- and triglycerides; polyethylene glycol (PEG) polymer in an amount of 5 % to 15 % by weight of the pharmaceutical composition; where the pharmaceutical composition does not contain an emulsifier. Pharmaceutical composition is prepared so that it is solid at a temperature of 15 °C or lower and has a melting point of 30 °C or higher. Invention also includes the use of this pharmaceutical composition in the manufacture of a medicinal agent for the treatment of chronic inflammation and a method of treating an individual suffering from chronic inflammation using the composition.
EFFECT: group of inventions allows to obtain a new pharmaceutical composition in the form of a solid solution.
46 cl, 4 dwg, 9 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITIONS AND METHODS FOR TREATING SEVERE PAIN | 2014 |
|
RU2677346C2 |
SOLID SOLUTION COMPOSITIONS AND USE IN CHRONIC INFLAMMATION | 2014 |
|
RU2675241C2 |
SOLID SOLUTION COMPOSITIONS AND THEIR USE IN CHRONIC INFLAMMATION | 2014 |
|
RU2779839C2 |
COMPOSITIONS AND METHODS FOR TREATMENT OF CHRONIC INFLAMMATION AND INFLAMMATORY DISEASES | 2012 |
|
RU2635188C2 |
SOLID SOLUTION COMPOSITIONS AND USE IN CARDIOVASCULAR DISEASE | 2014 |
|
RU2674982C2 |
SOLID SOLUTION COMPOSITIONS AND USE IN SEVERE PAIN | 2014 |
|
RU2667977C2 |
PERORAL COMPOSITIONS CONTAINING ESTER 17- HYDROXYPROHESTERON, AND CORRESPONDING METHODS | 2012 |
|
RU2640912C2 |
ANTISPASMODIC 1,2-DIOLS AND 1,2,3-TRIOLS | 2013 |
|
RU2657556C2 |
METHOD OF FOR MAKING LOZENGES CONTAINING NSAID, THEIR COMPOSITIONS AND APPLICATION IN MEDICINE | 2006 |
|
RU2403032C2 |
CONTROLLED RELEASE ANALGETIC SUSPENSIONS | 2004 |
|
RU2386434C2 |
Authors
Dates
2019-02-27—Published
2014-01-14—Filed